Plain-English translation of NCT05391061 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of Cibinqo, a medication used to treat moderate-to-severe atopic dermatitis (a serious skin condition that causes itching and inflammation). Researchers want to learn how well this medication works and how safe it is when patients take it during their normal routine doctor visits in Korea, rather than in a strict research setting.
Even though this medication has been approved for use, the company and doctors want to understand how it performs when real patients use it in everyday life—outside of controlled research trials—to make sure it continues to be safe and effective for people with severe eczema.
You likely qualify if…
You likely don't qualify if…
You will continue to see your regular doctor as you normally would, and your doctor will record information about how the medication is working for your skin and any side effects you experience. There are no extra scheduled visits or special procedures—the study simply gathers your medical information during your routine appointments. Your participation continues as long as you are taking this medication.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
South Korea